Effects of Metformin and its Combination with Teneligliptin or Empagliflozin on Bone Turnover Markers in Patients with Type 2 Diabetes Mellitus a prospective study

dc.contributor.guide	Vohora, Divya and Kohli, Sunil
dc.coverage.spatial
dc.creator.researcher	Shaik, Abdul Rahaman
dc.date.accessioned	2025-07-17T11:47:42Z
dc.date.available	2025-07-17T11:47:42Z
dc.date.awarded	2025
dc.date.completed	2024
dc.date.registered	2016
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent	x, 132p.
dc.identifier.researcherid
dc.identifier.uri	http://hdl.handle.net/10603/652864
dc.language	English
dc.publisher.institution	Department of Pharmacology
dc.publisher.place	Delhi
dc.publisher.university	Jamia Hamdard University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Effects of Metformin and its Combination with Teneligliptin or Empagliflozin on Bone Turnover Markers in Patients with Type 2 Diabetes Mellitus a prospective study
dc.title.alternative
dc.type.degree	Ph.D.